News


News Icon
Short-Term Sales Loss Doesn't Slow Down Intuitive Surgical (NASDAQ:ISRG) Much

If you've ever seen footage of that Da Vinci robotic surgery machine managing to peel a grape with a scalpel, then sew the skin back on, then you understand the impact Intuitive Surgical (NASDAQ:ISRG) has in the market.


News Icon
Big Gains for PayPal (NASDAQ:PYPL) as BTIG Hikes Its Rating

Being able to sell to customers who can't—or won't—walk into a physical store is crucial to ongoing business, especially when disasters strike and governments respond.  PayPal (NASDAQ:PYPL) proved to be a leader in the online shopping market


News Icon
Morgan Stanley (NYSE:MS) Lands a Hit With Jumps in Profit and Revenue

We've seen winners and losers alike crop up in the age of coronavirus, but perhaps one of the biggest surprises is Morgan Stanley (NYSE:MS). The company recently brought out an earnings report, and the word around that report is “beat.”


News Icon
Trouble Ahead for Tesla? (NASDAQ:TSLA) The Company Presses on China

Perhaps  the ultimate Cinderella story of 2020, Tesla (NASDAQ:TSLA) fought its way up to four-figure share prices, brought stock splits to investors, and made incredible headway, only failing to meet its latest goals by the slimmest of margins.


News Icon
Dropping American Express (NYSE:AXP) Could be a Mistake Right Now

American Express (NYSE:AXP) took a lot on the chin in 2020, but there are some exciting new points to recently emerge that suggest the company could be in for some substantial upward moves in the near-term.


News Icon
JPMorgan Chase (NYSE:JPM) Delivers Fantastic Results On Multiple Factors

If anyone is having a good day today, JPMorgan Chase (NYSE:JPM) is definitely on that list. New reports give the company some very favorable outlooks as multiple key measures deliver value for the company and its shareholders alike.


News Icon
Johnson & Johnson (NYSE: JNJ) Vaccine Looks Promising

It may appear that the vaccine race is over and Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are going to be responsible for most inoculations, but Johnson & Johnson (NYSE: JNJ) has other ideas


News Icon
Nordstrom (NYSE:JWN) Holiday Sales Disappoint, But the Future is Looking Up

Nordstrom (NYSE:JWN) Holiday Sales Disappoint, But the Future is Looking Up


News Icon
Terrible Christmas for Urban Outfitters (NASDAQ:URBN) as Holiday Sales Collapse

Urban Outfitters (NASDAQ:URBN) recently announced its holiday sales, and the result is a very Grinchly one indeed.


News Icon
Lemonade (NYSE:LMND) Sets Up a Nice Dip to Buy as New Offering Planned

Lemonade (NYSE:LMND), the online insurance operation, has discovered the consequences of thinning its mix too far down recently as it announced plans to roll out a new secondary share offering.


News Icon
Fresh Guidance for Gilead Sciences (NASDAQ:GILD) Proves a Welcome Balm

There is indeed a balm in Gilead today—specifically Gilead Sciences (NASDAQ:GILD)—as the company brought out some fresh news that captured investors' attention today,


News Icon
Goodyear Tire (NYSE:GT) Lands Upgrade from Keybanc

With used car sales seemingly making a comeback, Keybanc put out a new report that gave one big part of our cars a little extra life: Goodyear Tire and Rubber Company (NYSE:GT).


News Icon
Bill.com (NYSE: BILL) is Expensive, Is it Worth the Risk?

Bill.com (NYSE: BILL), which provides cloud-based payments technology for small and midsize (SMB) businesses to use for back office operations, is trading at 53.6x forward sales.


News Icon
Amazon’s (NASDAQ: AMZN) Growth Story Isn’t Near Its End

The opposite has been true for Amazon (NASDAQ: AMZN), however, if only by a bit. Over the past 20 quarters, Amazon’s revenue has grown at an average rate of 28.4%


News Icon
Citi Throws Micron Technology (NASDAQ:MU) a Double Upgrade Surprise

Sometimes stocks just start looking good, and for Citi, one of the most attractive issues around had to be Micron Technology (NASDAQ:MU). So attractive was this issue, in fact, that Citi jumped it from “sell” to “buy”


News Icon
Under Armour (NYSE:UAA) Improves Ratings, Makes Gains, Looks Impressive

Several substantial developments emerged to help close out the year for Under Armour (NYSE:UAA). With the first trading day of the new year already in progress, there's plenty of good news coming out that capitalizes on these developments


News Icon
Third Point Takes a Hand at Intel (NASDAQ:INTC), and You Should Follow Suit

hat's bringing in some exciting new dynamics to the chip market, and one of the latest features the Third Point hedge fund taking a hefty new stake in Intel (NASDAQ:INTC) and making new suggestions accordingly.


News Icon
Expedia Group (NASDAQ: EXPE) Stock is a Travel Recovery Play

Online travel company Expedia Group, Inc. (NASDAQ: EXPE) stock has recovered through its pre-COVID February pandemic  highs tracking evenly with the performance of the benchmark S&P 500 index (NYSEARCA: SPY).


News Icon
Guggenheim Looks for Growth From Levi Strauss (NYSE:LEVI)

It's that kind of endurance, and that kind of potential, that are likely drawing investors to Levi Strauss & Co. (NYSE:LEVI), and also drawing analysts like Guggenheim to bump up assessments and price targets.


News Icon
New Philip Morris (NYSE: PM) CEO Plans to Keep Company Moving Towards “Smoke-Free Future”

Philip Morris sold 60 billion RRP products in 2019, which was up 44% from 2018. The company thinks that its RRP growth story is still in the early innings


News Icon
AT&T (NYSE:T) Takes a Hit on “Wonder Woman 1984” Returns

The theaters may have taken an even bigger hit, and that in turn leads to bad news for studios like AT&T (NYSE:T), whose Warner Bros arm just saw a keystone production turn into a bomb by historical standards.


News Icon
Why Pool Retailer Leslie's is Making a Splash

One of the more underground, but interesting 2020 market debuts have been Phoenix-based Leslie's (NASDAQ:LESL).


News Icon
New Streaming Powerhouse? fuboTV Continues Upward Roll

The last several days have been fantastic for fuboTV (OTCMKTS:FUBO). The stock has gone continuously upward for the last week, with the standard break for the weekend thrown in.


News Icon
Time to Buy Peloton (NASDAQ:PTON) As It Makes Its Own New Buy

Peloton (NASDAQ:PTON) has come a long way since one particularly awkward advertising effort roughly this time last year. While some cringed at the thought of giving a young woman exercise equipment for Christmas,


News Icon
Nike (NYSE:NKE) Shows its Long- and Short-Distance Chops

if you had a sprinter with the endurance of a marathon runner, that would utterly change the game. Nike (NYSE:NKE) is showing its chops as both a long-distance runner and a short-distance runner as well


News Icon
COVID-19 Vaccines March On: A Status Report on the State of the Field

The massive worldwide horse race featuring multiple pharmaceutical companies working to pursue a vaccine for COVID-19 is rapidly coming to a conclusion,


News Icon
Sound Quarter for Accenture (NYSE:ACN) Demonstrates Its Value in a Portfolio

Granted, there aren't that many people who spend a lot of time thinking seriously about their accounting systems. For those who do, however, Accenture (NYSE:ACN) is one of the leaders in the field,


News Icon
Lifetime Brands (NASDAQ: LCUT) Stock is a “New Normal” Lifestyle Play

Consumer durables home and kitchenware products maker Lifetime Brands (NASDAQ: LCUT) stock is has vastly outperformed the benchmark S&P 500 index (NYSEARCA: SPY) by doublings its pre-pandemic highs.


News Icon
Planet Fitness (NYSE:PLNT) Slips on Negative Press, But Look Past the Hype

On the surface, negative press for Planet Fitness (NYSE:PLNT) would make sense. After all, it's one of the leading firms—arguably the leader—in the whole gym market,


News Icon
AstraZeneca Picks Up Alexion Pharmaceuticals: Why You Should Too

While AstraZeneca (LON:AZN) is a bit behind the eight-ball in the race for a COVID-19 vaccine—especially given that the first batch of doses have already rolled off the loading docks at a competitor—it's working to cement its status as being more than a one-note operation